Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation

You Song and Daniel L. Villeneuve

No 28, OECD Series on Adverse Outcome Pathways from OECD Publishing

Abstract: This Adverse Outcome Pathway (AOP) describes the linkage between uncoupling of oxidative phosphorylation (OXPHOS) and growth inhibition via decreased cell proliferation. The mitochondrial OXPHOS machinery is a key physiological process responsible for producing the primary cellular energy, adenosine triphosphate (ATP). Uncoupling of OXPHOS is a well-known mechanism of action of many chemicals and can affect many ATP-dependent biological functions. Cell proliferation in particular, as a major process to achieve organismal growth, is positively correlated with the cellular ATP level and highly susceptible to energy depletion. This AOP causally links uncoupling of OXPHOS to growth inhibition, through ATP depletion and reduced cell proliferation with strong weight of evidence support. This AOP is of high regulatory relevance, as it is considered applicable to both human health and ecological risk assessments. The AOP also forms the core of a larger AOP network addressing uncoupling of OXPHOS mediated growth inhibition. This AOP is referred to as AOP 263 in the Collaborative Adverse Outcome Pathway Wiki (AOP-Wiki).

Keywords: Adenosine triphosphate; Cell proliferation; oxidative phosphorylation (search for similar items in EconPapers)
Date: 2022-12-15
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1787/f20867c1-en (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oec:envaad:28-en

Access Statistics for this paper

More papers in OECD Series on Adverse Outcome Pathways from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by ().